As a supplier of Heparin sodium salt, I am often asked about its chemical structure. Heparin sodium salt is a complex and highly sulfated glycosaminoglycan (GAG) that plays a crucial role in various biological processes, particularly in anticoagulation. Understanding its chemical structure is essential for appreciating its biological functions and for its use in pharmaceutical applications.
Basic Chemical Composition
Heparin sodium salt is composed of repeating disaccharide units. These disaccharide units typically consist of a uronic acid and a glucosamine. The uronic acid can be either L - iduronic acid (IdoA) or D - glucuronic acid (GlcA), and the glucosamine is usually N - sulfated or N - acetylated.
The basic disaccharide building blocks of heparin sodium salt can be represented as follows:
-
Uronic Acid Component:
- D - Glucuronic acid has a six - membered ring structure with a carboxylic acid group at the C - 6 position. It has a relatively rigid conformation due to the equatorial orientation of most of its substituents.
- L - Iduronic acid, on the other hand, has a more flexible structure. It can adopt different conformations, which is important for the binding of heparin to various proteins. The iduronic acid residue in heparin is often sulfated at the C - 2 position.
-
Glucosamine Component:
- The glucosamine in heparin sodium salt is commonly N - sulfated or N - acetylated at the C - 2 position. Additionally, it can be sulfated at the C - 6 position and sometimes at the C - 3 position. The N - sulfation of glucosamine is a characteristic feature of heparin and contributes significantly to its negative charge.
Sulfation Patterns
One of the most distinctive features of heparin sodium salt is its high degree of sulfation. Sulfate groups are attached to different positions on the disaccharide units, which gives heparin a highly negative charge density. This negative charge is crucial for its biological activities, especially its ability to bind to positively charged proteins.
- 2 - O - Sulfation: This occurs on the uronic acid residues, mainly on L - iduronic acid. The 2 - O - sulfate group enhances the flexibility of the iduronic acid residue and is important for the binding of heparin to antithrombin III, a key protein in the anticoagulation pathway.
- 6 - O - Sulfation: Found on the glucosamine residues, 6 - O - sulfation is also significant for the interaction of heparin with various proteins. It can affect the overall conformation of the heparin chain and its binding affinity.
- 3 - O - Sulfation: Although less common than 2 - O - and 6 - O - sulfation, 3 - O - sulfation on glucosamine is essential for the specific binding of heparin to antithrombin III. Only a small fraction of heparin chains contain 3 - O - sulfated glucosamine residues, but these residues are critical for the anticoagulant activity of heparin.
Chain Length and Polydispersity
Heparin sodium salt exists as a heterogeneous mixture of polysaccharide chains with different lengths. The average molecular weight of heparin can range from about 3000 to 30000 Da, but there is a wide distribution of chain lengths within a given sample. This polydispersity is a result of the biosynthetic process in which heparin is produced.
The chain length of heparin can affect its biological activity. For example, shorter heparin chains may have different binding properties compared to longer chains. Shorter chains may have reduced anticoagulant activity because they may not be able to bind to multiple proteins simultaneously as effectively as longer chains.


Biological Significance of the Chemical Structure
The unique chemical structure of heparin sodium salt is directly related to its biological functions.
- Anticoagulation: Heparin binds to antithrombin III, inducing a conformational change in antithrombin III that greatly enhances its ability to inhibit thrombin and other coagulation factors. The specific sulfation patterns and the flexibility of the heparin chain are crucial for this interaction. The 3 - O - sulfated glucosamine residues are particularly important for the high - affinity binding of heparin to antithrombin III, which leads to the rapid inactivation of thrombin and the prevention of blood clot formation.
- Cell - Cell and Cell - Matrix Interactions: Heparin can interact with a variety of proteins, including growth factors, cytokines, and adhesion molecules. Its negative charge allows it to bind to positively charged regions on these proteins, modulating their activity and function. For example, heparin can bind to fibroblast growth factors (FGFs) and enhance their binding to their receptors, thereby promoting cell proliferation and differentiation.
Our Heparin Sodium Salt Products
As a supplier of Heparin sodium salt, we ensure that our products meet the highest quality standards. Our heparin sodium salt is carefully extracted and purified to maintain its natural chemical structure and biological activity. We use advanced purification techniques to remove impurities and ensure the consistency of our products.
Our Heparin sodium salt can be used in a wide range of applications, including pharmaceutical manufacturing, research, and medical diagnostics. Whether you are developing a new anticoagulant drug or conducting basic research on heparin - protein interactions, our products can provide you with reliable and high - quality materials.
In addition to Heparin sodium salt, we also offer other high - quality products such as Ibuprofen API (CAS#15687 - 27 - 1), Doxycycline|CAS 564 - 25 - 0, and D - Serine CAS#312 - 84 - 5. These products are also carefully selected and tested to ensure their quality and purity.
Contact Us for Purchase and Collaboration
If you are interested in purchasing Heparin sodium salt or any of our other products, we encourage you to contact us for further discussions. Our team of experts is ready to provide you with detailed information about our products, including their chemical properties, biological activities, and application methods. We can also offer customized solutions based on your specific requirements.
Whether you are a large - scale pharmaceutical manufacturer or a small - scale research institution, we are committed to providing you with the best products and services. Don't hesitate to reach out to us and start a fruitful collaboration.
References
- Lindahl, U., & Hook, M. (1978). Structure and biological interactions of heparin. Annual Review of Biochemistry, 47(1), 385 - 417.
- Casu, B., & Lindahl, U. (2001). Heparin - protein interactions. European Journal of Biochemistry, 268(16), 4413 - 4430.
- Capila, I., & Linhardt, R. J. (2002). Heparin - protein interactions. Angewandte Chemie International Edition, 41(18), 391-412.
